Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.
Pignata S, De Placido S, Biamonte R, Scambia G, Di Vagno G, Colucci G, Febbraro A, Marinaccio M, Lombardi AV, Manzione L, Cartenì G, Nardi M, Danese S, Valerio MR, de Matteis A, Massidda B, Gasparini G, Di Maio M, Pisano C, Perrone F.
Pignata S, et al. Among authors: di vagno g, di maio m.
BMC Cancer. 2006 Jan 7;6:5. doi: 10.1186/1471-2407-6-5.
BMC Cancer. 2006.
PMID: 16398939
Free PMC article.
Clinical Trial.